Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Tubaro

Showing results (11-20 of 331) with videos related to

Pageof 34
Sort By:
European Urology|April 15, 2004
Re: See W, Iversen P, Wirth M, McLeod D, Garside L, Morris T. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer. Eur Urol 2003;44:512-8Andrea Tubaro, Cosimo De Nunzio
Nature Reviews. Urology|December 5, 2012
Prostate cancer: Diabetes and prostate cancer--an open debateCosimo De Nunzio, Andrea Tubaro
European Urology|March 16, 2015
Re: Christian Gratzke, Alexander Bachmann, Aurelien Descazeaud, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol 2015;67:1099-109Andrea Tubaro, Cosimo De Nunzio
BJU International|August 23, 2018
Exercise to prevent lower urinary tract symptoms: myth and realityAndrea Tubaro, Cosimo De Nunzio
Nature Reviews. Urology|November 30, 2011
BPH: unmet needs in managing LUTS--a European perspectiveCosimo De Nunzio, Andrea Tubaro
European Urology|May 20, 2004
The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian surveyAndrea Tubaro, Carlo La Vecchia,
European Urology|October 4, 2011
Words of wisdom. Re: Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)Andrea Tubaro, Cosimo De Nunzio
Nature Reviews. Urology|January 7, 2015
Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatmentCosimo De Nunzio, Andrea Tubaro
European Urology Focus|July 21, 2017
Grey Zone: Urinary IncontinenceAndrea Tubaro, Arjun K Nambiar,
BJU International|July 6, 2013
Flexible dose fesoterodine in the treatment of overactive bladder (OAB)Andrea Tubaro, Cosimo De Nunzio
Pageof 34

Showing results (11-20 of 331) with videos related to

Sort By:
Pageof 34
European Urology|April 15, 2004
Re: See W, Iversen P, Wirth M, McLeod D, Garside L, Morris T. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer. Eur Urol 2003;44:512-8Andrea Tubaro, Cosimo De Nunzio
Nature Reviews. Urology|December 5, 2012
Prostate cancer: Diabetes and prostate cancer--an open debateCosimo De Nunzio, Andrea Tubaro
European Urology|March 16, 2015
Re: Christian Gratzke, Alexander Bachmann, Aurelien Descazeaud, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol 2015;67:1099-109Andrea Tubaro, Cosimo De Nunzio
BJU International|August 23, 2018
Exercise to prevent lower urinary tract symptoms: myth and realityAndrea Tubaro, Cosimo De Nunzio
Nature Reviews. Urology|November 30, 2011
BPH: unmet needs in managing LUTS--a European perspectiveCosimo De Nunzio, Andrea Tubaro
European Urology|May 20, 2004
The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian surveyAndrea Tubaro, Carlo La Vecchia,
European Urology|October 4, 2011
Words of wisdom. Re: Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)Andrea Tubaro, Cosimo De Nunzio
Nature Reviews. Urology|January 7, 2015
Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatmentCosimo De Nunzio, Andrea Tubaro
European Urology Focus|July 21, 2017
Grey Zone: Urinary IncontinenceAndrea Tubaro, Arjun K Nambiar,
BJU International|July 6, 2013
Flexible dose fesoterodine in the treatment of overactive bladder (OAB)Andrea Tubaro, Cosimo De Nunzio
Pageof 34